Dengvaxia

News

Takeda pulls its dengue vaccine filing from FDA

Takeda has unexpectedly withdrawn its marketing application with the FDA for dengue fever vaccine TAK-003 and said it will reconsider whether it will attempt to bring it t

News

Dengue, zika and chikungunya fever mosquito (aedes aegypti) on human skin

FDA starts speedy review of Takeda's dengue vaccine

The US regulator has started a priority, six-month review of Takeda's dengue fever vaccine TAK-003 – tipped as a potential blockbuster product – making a decision likely in the first half o

News

Takeda gets first approval for its dengue vaccine

Japan's Takeda has secured its first regulatory approval – in Indonesia – for its dengue fever vaccine TAK-003, which has been tipped as a potential blockbuster product.

News

Takeda bolsters data for dengue jab as regulatory reviews ro...

Takeda has reported positive new, long-term results in its pivotal trial of dengue fever vaccine TAK-003 that builds the case for the shot as regulators review marketing applications.

News

After Sanofi's setbacks, Takeda eyes finish line with its de...

Takeda has revealed long-term clinical trial results with its dengue vaccine that reinforce its safety and efficacy – and help to differentiate it from Sanofi's challenged Dengvaxia shot.

News